MedPath

A clinical trail to study the effect of intrathecal Dexmeditomidine with Magnesium sulphate as an additional adjuvant to intrathecal Morphine and Bupivacaine combination for post operative analgesia in patients undergoing major abdominal surgeries.

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/063906
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients Aged 18-65years.

2.Patients belonging to American society of anaesthesiologists (ASA PS) physical status grade I, II and III .

3.Patients scheduled to undergo major abdominal surgeries with expected duration of 3 to 4 hrs and

4.Patients willing to give the written consent to participate in the study will be included in the study.

Exclusion Criteria

Patients who are not willing to participate in the study.

Patients with history of intolerance or showing anaphylactic reaction to the medications used in the study.

Patients with severe hepatic, renal, cardiac and neurological disorders.

Pregnant and lactating women.

Patients who cannot understand or interpret VAS for pain assessment and

Patients who could not be positioned for regional technique post-surgery will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath